ArticleInvestigational new drugs2018
A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine.
Akihiko Ozaki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it